| CPC C07D 401/12 (2013.01) [A61P 17/12 (2018.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 417/06 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01)] | 44 Claims |
|
1. A compound of formula (XXXII):
![]() or a pharmaceutically acceptable salt, racemate, or stereoisomer thereof,
wherein;
G is pyridinyl pyrazinyl, or thiazolyl;
A is
![]() wherein* is bond to E or pyrrolidinyl ring of formula XXXII);
E is phenyl or pyrazinyl;
each R1 is independently cyano, nitro, hydroxy, halo, C1-C3 haloalkyl, C1-C3 haloalkoxy, C1-C6 alkyl, C1-C6 alkoxy, ether, aryl, —N(Ra)(Rb), —C(O) Rc, —CO2Rc, —C(O)N(Ra)(Rb), —SO2N(Ra)(Rb), or —SORc,
or two R1 groups together form a ring system;
each R2 and R3 is independently cyano, nitro, hydroxy, halo, C1-C3 haloalkyl, C1-C3 haloalkoxy, C1-C6 alkyl, hydroxyalkyl, C3-C8 cycloalkyl, C1-C6 alkoxy, aryl, —N(Ra)(Rb), —C(O)Rc, —CH2Rc, —CO2Rc, —C(O)N(Ra)(Rb), —SO2N(Ra)(Rb), or —SORc; each Ra and Rb is independently H, hydroxyl, —ORc, C1-C6 alkyl, —C(O)Rc, or —C(O)ORc; each Rc is independently H, C1-C6 alkyl, or aryl;
n is 0, 1, or 2; p is 1, or 2; and q is 0, 1, or 2.
|